ReSynapse Therapeutics
Novel Multi-Target Neuropsychiatric Drugs via Computational Drug Design
Active
Pre-Seed
Startup
Ness Ziona
Founded 2024-12
ReSynapse Therapeutics is a biotechnology company developing selective multi-target small molecules for treatment-resistant depression. Using systematic computational drug design, we identify compounds that precisely modulate multiple serotonin receptors simultaneously. Our approach combines validated receptor biology with proprietary computational methodol…
SectorHealth Tech & Life Sciences
StagePre-Seed
Employees2
Founded2024-12
HQNess Ziona
Confidence80
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Platforms & Interfaces
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals